SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer

BACKGROUND: Detection of aberrant methylated DNA in the stool is an effective early screening method for colorectal cancer (CRC). Previously, reporters identified that syndecan-2 (SDC2) and tissue factor pathway inhibitor 2 (TFPI2) were aberrantly methylated in most CRC tissues. However, the combine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weisong, Yang, Chaogang, Wang, Shuyi, Xiang, Zhenxian, Dou, Rongzhang, Lin, Zaihuan, Zheng, Jinsen, Xiong, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096344/
https://www.ncbi.nlm.nih.gov/pubmed/33958894
http://dx.doi.org/10.2147/CMAR.S300861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096344/
https://www.ncbi.nlm.nih.gov/pubmed/33958894
http://dx.doi.org/10.2147/CMAR.S300861

Ejemplares similares